CPC Biotech Launched to Offer a Fluid Management Component Portfolio

CPC Biotech was launched as a combined entity that brings together the connector technology of CPC and the flow control expertise of PSG Biotech. The goal is to create a fluid management component portfolio.

Operating under the CPC Biotech brand as part of PSG, the new company, says a spokesperson, will serve as a single source for sterile connectors, low-shear pumps, flow meters, and sensors.

“We will drive increased innovation to better serve our customers and help advance the biopharma industry,” said John Boehm, general manager, CPC Biotech.

CPC Biotech’s solutions support a range of bioprocessing applications, spanning the upstream and downstream biologic drug manufacturing process, as well as cell and gene therapy production, according to Boehm. The company’s products are manufactured across facilities in North America, Europe, and Asia, with customers in more than 50 countries through a network of channel partners.

CPC Biotech will make its public debut at INTERPHEX 2026, taking place April 21–23 at the Jacob K. Javits Convention Center in New York City, located at Booth #3129.

The post CPC Biotech Launched to Offer a Fluid Management Component Portfolio appeared first on GEN - Genetic Engineering and Biotechnology News.